journal article·2018-10-10

Drug-Loaded Halloysite Nanotube-Reinforced Electrospun Alginate-Based Nanofibrous Scaffolds with Sustained Antimicrobial Protection

Rangika Thilan De Silva, Ranga K. Dissanayake, M. M. M. G. Prasanga Gayanath Mantilaka, W. P. Sanjeewa Lakmal Wijesinghe, Shehan Shalinda Kaleel, Thejani Nisansala Premachandra, Laksiri Weerasinghe, Gehan A. J. Amaratunga, K. M. Nalin de Silva

ACS Applied Materials & Interfaces· Volume 10· Issue 40
Publisher page

Abstract

Halloysite nanotube (HNT)-reinforced alginate-based nanofibrous scaffolds were successfully fabricated by electrospinning to mimic the natural extracellular matrix (ECM) structure which is beneficial for tissue regeneration. An antiseptic drug, cephalexin (CEF)-loaded HNT, was incorporated into the alginate-based matrix to obtain sustained antimicrobial protection and robust mechanical properties, the key criteria for tissue engineering applications. Electron microscopic imaging and drug release studies revealed that CEF had penetrated into the lumen space of the HNT and also deposited on the outer walls, with a total loading capacity of 30 wt %. Moreover, the diameter of alginate-based nanofibers of the scaffolds ranged from 40 to 522 nm with well-aligned HNTs, resulting in superior mechanical properties. For instance, the addition of 5% (w/w) HNT improved the tensile strength (σ) and elastic modulus by 3-fold and 2-fold, respectively, compared to those of the alginate-based scaffolds without HNT. The fabricated scaffolds exhibited remarkable antimicrobial properties against both Gram-negative and Gram-positive bacteria, and the cytotoxicity studies confirmed the nontoxicity of the fabricated scaffolds. Drug release kinetics showed that CEF inside HNTs diffuses within 24 h and that the diffusion of the drug is delayed by 7 days once the CEF-loaded HNTs are incorporated into the alginate-based nanofibers. These fabricated alginate-based electrospun scaffolds with enhanced mechanical properties and sustained antimicrobial protection hold great potential to be used as artificial ECM scaffolds for tissue engineering applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Clay minerals and soil interactions · Therapeutic Uses of Natural Elements · Iron oxide chemistry and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Sri Lanka Institute of Nanotechnology (SLINTEC), Nanotechnology and Science Park, Mahenwatte, Pitipana, Homagama 10200, Sri Lanka

Department of Veterinary Pathobiology, Faculty of Veterinary Medicine, University of Peradeniya, Peradeniya 20400, Sri Lanka

Electrical Engineering Division, Department of Engineering, University of Cambridge, 9 J. J. Thomson Avenue, Cambridge CB3 0FA, U.K.

Department of Chemistry, University of Colombo, Colombo 00300, Sri Lanka

References (46)

Show source-provided references
1. 10.1111/j.1600-0501.2010.01922.x10.1111/j.1600-0501.2010.01922.x ↗
2. 10.1021/nn506255e10.1021/nn506255e ↗
3. 10.1016/j.biomaterials.2016.10.04010.1016/j.biomaterials.2016.10.040 ↗
4. 10.1016/j.eurpolymj.2017.08.01710.1016/j.eurpolymj.2017.08.017 ↗
5. 10.1016/j.actbio.2016.01.00510.1016/j.actbio.2016.01.005 ↗
6. 10.1016/j.biomaterials.2017.06.00510.1016/j.biomaterials.2017.06.005 ↗
7. 10.1155/2017/139129810.1155/2017/1391298 ↗
8. 10.1016/j.biomaterials.2013.09.09710.1016/j.biomaterials.2013.09.097 ↗
9. 10.1016/j.carbpol.2015.12.07510.1016/j.carbpol.2015.12.075 ↗
10. 10.1016/j.actbio.2015.08.04410.1016/j.actbio.2015.08.044 ↗
11. 10.1016/j.msec.2017.03.30610.1016/j.msec.2017.03.306 ↗
12. 10.1039/c6ra25023h10.1039/c6ra25023h ↗
13. 10.1016/j.ijbiomac.2014.07.00810.1016/j.ijbiomac.2014.07.008 ↗
14. 10.1002/mabi.20100004610.1002/mabi.201000046 ↗
15. 10.1021/bp010070p10.1021/bp010070p ↗
16. 10.1016/j.polymer.2006.09.02710.1016/j.polymer.2006.09.027 ↗
17. 10.1007/s10856-013-4957-710.1007/s10856-013-4957-7 ↗
18. 10.1263/jbb.100.4310.1263/jbb.100.43 ↗
19. 10.1002/app.2863410.1002/app.28634 ↗
20. 10.1016/j.ijbiomac.2011.04.00510.1016/j.ijbiomac.2011.04.005 ↗
21. 10.1002/polb.2178410.1002/polb.21784 ↗
22. 10.1180/claymin.2016.051.3.1510.1180/claymin.2016.051.3.15 ↗
23. 10.1180/claymin.2016.051.3.1410.1180/claymin.2016.051.3.14 ↗
24. 10.1016/j.progpolymsci.2014.04.00410.1016/j.progpolymsci.2014.04.004 ↗
25. 10.1016/j.cej.2017.02.06510.1016/j.cej.2017.02.065 ↗
26. 10.1016/j.msec.2015.01.03710.1016/j.msec.2015.01.037 ↗
27. 10.1016/j.clay.2015.10.03210.1016/j.clay.2015.10.032 ↗
28. 10.1016/j.clay.2014.09.00710.1016/j.clay.2014.09.007 ↗
29. 10.1016/j.porgcoat.2017.05.01810.1016/j.porgcoat.2017.05.018 ↗
30. 10.1021/acsami.7b0429710.1021/acsami.7b04297 ↗
31. 10.1016/j.carbpol.2016.07.04110.1016/j.carbpol.2016.07.041 ↗
32. 10.1016/j.ijbiomac.2018.01.16310.1016/j.ijbiomac.2018.01.163 ↗
33. 10.1016/j.clay.2017.12.01610.1016/j.clay.2017.12.016 ↗
34. 10.1016/j.clay.2014.06.00210.1016/j.clay.2014.06.002 ↗
35. 10.1021/acsami.7b1936110.1021/acsami.7b19361 ↗
36. 10.1039/c7tb00297a10.1039/c7tb00297a ↗
37. 10.1039/c8tb00543e10.1039/c8tb00543e ↗
38. 10.1203/pdr.0b013e31816c5bc310.1203/pdr.0b013e31816c5bc3 ↗
39. 10.1063/1.490632510.1063/1.4906325 ↗
40. 10.1116/1.349461710.1116/1.3494617 ↗
41. 10.1016/j.etap.2008.06.00210.1016/j.etap.2008.06.002 ↗
42. 10.1016/j.msec.2016.02.05310.1016/j.msec.2016.02.053 ↗
43. 10.1016/j.porgcoat.2015.01.01910.1016/j.porgcoat.2015.01.019 ↗
44. 10.1016/j.jmbbm.2015.02.00610.1016/j.jmbbm.2015.02.006 ↗
45. 10.1016/j.msec.2016.04.06810.1016/j.msec.2016.04.068 ↗
46. 10.1016/j.ijbiomac.2016.10.08510.1016/j.ijbiomac.2016.10.085 ↗